INTRANASAL ADMINISTRATION OF A MENINGOCOCCAL OUTER-MEMBRANE VESICLE VACCINE INDUCES PERSISTENT LOCAL MUCOSAL ANTIBODIES AND SERUM ANTIBODIES WITH STRONG BACTERICIDAL ACTIVITY IN HUMANS
B. Haneberg et al., INTRANASAL ADMINISTRATION OF A MENINGOCOCCAL OUTER-MEMBRANE VESICLE VACCINE INDUCES PERSISTENT LOCAL MUCOSAL ANTIBODIES AND SERUM ANTIBODIES WITH STRONG BACTERICIDAL ACTIVITY IN HUMANS, Infection and immunity, 66(4), 1998, pp. 1334-1341
A nasal vaccine, consisting of outer membrane vesicles (OMVs) from gro
up B Neisseria meningitidis, was given to 12 volunteers in the form of
nose drops or nasal spray four times at weekly intervals, with a fift
h dose 5 months later, Each nasal dose consisted of 250 mu g of protei
n, equivalent to 10 times the intramuscular dose that was administered
twice with a 6-week interval to 11 other volunteers. All individuals
given the nasal vaccine developed immunoglobulin A (IgA) antibody resp
onses to OMVs in nasal secretions, and eight developed salivary IgA an
tibodies which persisted for at least 5 months, Intramuscular immuniza
tions did not lead to antibody responses in the secretions. Modest inc
reases in serum IgG antibodies were obtained in 5 volunteers who had b
een immunized intranasally, while 10 individuals responded strongly to
the intramuscular vaccine. Both the serum and secretory antibody resp
onses reached a maximum after two to three doses of the nasal vaccine,
with no significant booster effect of the fifth dose, The pattern of
serum antibody specificities against the different OMV components afte
r intranasal immunizations was largely similar to that obtained with t
he intramuscular vaccine. Five and eight vaccinees in the nasal group
developed persistent increases in serum bactericidal titers to the hom
ologous meningococcal vaccine strain expressing low and high levels, r
espectively, of the outer membrane protein Ope. Our results indicate t
hat meningococcal OMVs possess the structures necessary to initiate sy
stemic as well as local mucosal immune responses when presented as a n
asal vaccine. Although the serum antibody levels were less conspicuous
than those after intramuscular vaccinations, the demonstration of sub
stantial bactericidal activity indicates that a nonproliferating nasal
vaccine might induce antibodies of high functional quality.